Jennifer Ligon-Gaston
Family · Montgomery, TXNPI 1780037861
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $934 and has fallen 96.8% since, to $30 in 2025.
Across 66 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$238
- AbbVie$161
- Merz North America, Inc.$155
- Galderma Laboratories, L.p.$145
- Novo Nordisk$56
- Bayer$45
- plus $410 from 19 others
What the payments were for
- Food & beverage$1,210100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $238 |
| AbbVie | 12 | $161 |
| Merz North America, Inc. | 1 | $155 |
| Galderma Laboratories, L.p. | 5 | $145 |
| Novo Nordisk | 4 | $56 |
| Bayer | 2 | $45 |
| Novartis | 2 | $38 |
| GSK | 2 | $38 |
| Dexcom, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Antares Pharma, Inc. | 2 | $28 |
| Lilly USA, LLC | 2 | $25 |
| Astellas Pharma US Inc | 1 | $25 |
| Genentech USA, Inc. | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Abbott | 1 | $21 |
| Amgen | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Bausch Health US, LLC | 1 | $13 |
| Clarus Therapeutics Inc. | 2 | $11 |
How this compares
$1,210 in reported general payments places this provider in the 70th percentile of 15,456 family providers in Texas.
Other family in Montgomery
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.